Skip to content
1887

Access Microbiology open research platform logo Access Microbiology

Volume 6, Issue 10

The complete genome sequence of five pre-2013 sequence type (ST)1193 strains reveals insights into an emerging pathogen Open Access

Abstract

Fluoroquinolone-resistant sequence type (ST)1193 is a profound, emerging lineage associated with systemic, urinary tract and neonatal infections. Humans, companion animals and the environment are reservoirs for ST1193, which has been disseminated globally. Following its detection in 2007, ST1193 has been identified repeatedly amongst fluoroquinolone-resistant clones in Australia. However, despite the growing importance of ST1193, only three complete genomes are published in the literature, none of which are from Australia. Here we expand on the available ST1193 resources with the complete genomes of five ST1193 strains sequenced using Oxford Nanopore Technologies and Illumina. Using genotyping, we found that all strains were multi-drug resistant, including resistances to fluoroquinolones and cephalosporins. antibiotic susceptibility testing mostly correlated with individual genotypes. The exception was MS8320, which had additional resistance to piperacillin/tazobactam, ampicillin/sulbactam, cefazolin and doripenem (carbapenem). Further investigation identified seven additional copies of an IS26 transposable unit carrying a beta-lactamase gene, suggesting this tandem amplification is associated with extended resistance phenotypes. Uropathogenicity factors, including three separate siderophore-encoding loci, were conserved in chromosomal and plasmid regions. Using all complete genomes, we further elucidated the recombination events surrounding the previously described K5/K1 capsular locus switch. Phenotypic confirmation of differing capsules in Australian ST1193 strains, coupled with genetic analysis revealing insertions downstream of the capsular locus, underscored the genetic distinctions between K5 and K1 capsule encoding strains. This study provides five new reference ST1193 genomes from Australia. These include the earliest complete K5-capsule ST1193 genomes on record (collected 2007), alongside our reference genome (MS10858), a clinical isolate obtained early during the ST1193 expansion and representative of the predominant K1-associated clade. These findings lay the foundations for further genomic and molecular analyses that may help understand the underlying reasons for the rapid global expansion of ST1193.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): antibiotic resistance , capsule , long-read sequencing , mobile genetic elements and phylogenetic analysis
Funding
This study was supported by the:
  • National Health and Medical Research Council (Award GNT1067455)
    • Principal Award Recipient: MarkA. Schembri
  • National Health and Medical Research Council (Award GNT1067455)
    • Principal Award Recipient: ScottA. Beatson
  • Australian Research Council (Award LP130100736)
    • Principal Award Recipient: ScottA. Beatson
© 2024 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/acmi/10.1099/acmi.0.000894.v3
2024-10-18
2026-04-14

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/acmi/6/10/acmi000894.v3.html?itemId=/content/journal/acmi/10.1099/acmi.0.000894.v3&mimeType=html&fmt=ahah

References

  1. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002; 113:5–13 [View Article] [PubMed]
     [Google Scholar]
  2. Stamm WE. Scientific and clinical challenges in the management of urinary tract infections. Am J Med 2002; 113:1–4 [View Article] [PubMed]
     [Google Scholar]
  3. Acar JF, Goldstein FW. Trends in bacterial resistance to fluoroquinolones. Clin Infect Dis 1997; 24:S67-S73 [View Article] [PubMed]
     [Google Scholar]
  4. Hensley S. Cipro loses share in traditional market, as doctors seek other cures in shortage. Wall Street J 2001
     [Google Scholar]
  5. Cheng AC, Turnidge J, Collignon P, Looke D, Barton M et al. Control of fluoroquinolone resistance through successful regulation, Australia. Emerg Infect Dis 2012; 18:1453–1460 [View Article]
     [Google Scholar]
  6. White RT. Escherichia coli: placing resistance to third-generation cephalosporins and fluoroquinolones in Australia and New Zealand into perspective. Microbiol Aust 2021; 42:104–110 [View Article]
     [Google Scholar]
  7. Australian Commission on Safety and Quality in Health Care AURA 2023: fifth Australian report on antimicrobial use and resistance in human health. Sydney, Australia: Australian Commission on Safety and Quality in Health Care; 2023 https://www.safetyandquality.gov.au/publications-and-resources/resource-library/aura-2023-fifth-australian-report-antimicrobial-use-and-resistance-human-health-report accessed 9 July 2021
  8. World Health Organization Critically important antimicrobials for human medicine. 5 ed. Geneva: Switzerland; 2017 https://www.who.int/publications/i/item/9789241512220 accessed 9 July 2021
  9. World Health Organization Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2017-2018. Geneva, Switzerland. World Health Organization; 2017 https://www.who.int/publications/i/item/9789241513449 accessed 30 June 2022
  10. Ben Zakour NL, Alsheikh-Hussain AS, Ashcroft MM, Khanh Nhu NT, Roberts LW et al. Sequential acquisition of virulence and fluoroquinolone resistance has shaped the evolution of Escherichia coli ST131. mBio 2016; 7:e00347-16 [View Article] [PubMed]
     [Google Scholar]
  11. Stoesser N, Sheppard AE, Pankhurst L, De Maio N, Moore CE et al. Evolutionary history of the global emergence of the Escherichia coli epidemic clone ST131. mBio 2016; 7:e02162 [View Article] [PubMed]
     [Google Scholar]
  12. Kallonen T, Brodrick HJ, Harris SR, Corander J, Brown NM et al. Systematic longitudinal survey of invasive Escherichia coli in England demonstrates a stable population structure only transiently disturbed by the emergence of ST131. Genome Res 2017; 27:1437–1449 [View Article]
     [Google Scholar]
  13. Johnson TJ, Elnekave E, Miller EA, Munoz-Aguayo J, Flores Figueroa C et al. Phylogenomic analysis of extraintestinal pathogenic Escherichia coli sequence type 1193, an emerging multidrug-resistant clonal group. Antimicrob Agents Chemother 2019; 63: [View Article]
     [Google Scholar]
  14. Ludden C, Decano AG, Jamrozy D, Pickard D, Morris D et al. Genomic surveillance of Escherichia coli ST131 identifies local expansion and serial replacement of subclones. Microb Genom 2020; 6:e000352 [View Article] [PubMed]
     [Google Scholar]
  15. White RT, Bull MJ, Barker CR, Arnott JM, Wootton M et al. Genomic epidemiology reveals geographical clustering of multidrug-resistant Escherichia coli ST131 associated with bacteraemia in Wales. Nat Commun 2024; 15:1371 [View Article] [PubMed]
     [Google Scholar]
  16. Forde BM, Roberts LW, Phan M-D, Peters KM, Fleming BA et al. Population dynamics of an Escherichia coli ST131 lineage during recurrent urinary tract infection. Nat Commun 2019; 10:3643 [View Article] [PubMed]
     [Google Scholar]
  17. Petty NK, Ben Zakour NL, Stanton-Cook M, Skippington E, Totsika M et al. Global dissemination of a multidrug resistant Escherichia coli clone. Proc Natl Acad Sci USA 2014; 111:5694–5699 [View Article]
     [Google Scholar]
  18. Price LB, Johnson JR, Aziz M, Clabots C, Johnston B et al. The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H 30-Rx. mBio 2013; 4:e00377-13 [View Article]
     [Google Scholar]
  19. Platell JL, Cobbold RN, Johnson JR, Trott DJ. Clonal group distribution of fluoroquinolone-resistant Escherichia coli among humans and companion animals in Australia. J Antimicrob Chemother 2010; 65:1936–1938 [View Article]
     [Google Scholar]
  20. Peirano G, Matsumara Y, Nobrega D, DeVinney R, Pitout J. Population-based epidemiology of Escherichia coli ST1193 causing blood stream infections in a centralized Canadian region. Eur J Clin Microbiol Infect Dis 2021 [View Article]
     [Google Scholar]
  21. Iqbal J, Dufendach KR, Wellons JC, Kuba MG, Nickols HH et al. Lethal neonatal meningoencephalitis caused by multi-drug resistant, highly virulent Escherichia coli. Infect Dis 2016; 48:461–466 [View Article] [PubMed]
     [Google Scholar]
  22. Ding Y, Zhang J, Yao K, Gao W, Wang Y. Molecular characteristics of the new emerging global clone ST1193 among clinical isolates of Escherichia coli from neonatal invasive infections in China. Eur J Clin Microbiol Infect Dis 2021; 40:833–840 [View Article]
     [Google Scholar]
  23. Tchesnokova VL, Rechkina E, Larson L, Ferrier K, Weaver JL et al. Rapid and extensive expansion in the United States of a new multidrug-resistant Escherichia coli clonal group, sequence type 1193. Clin Infect Dis 2019; 68:334–337 [View Article] [PubMed]
     [Google Scholar]
  24. Harris PN, Peleg AY, Iredell J, Ingram PR, Miyakis S et al. Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial. Trials 2015; 16:24 [View Article] [PubMed]
     [Google Scholar]
  25. Xia L, Liu Y, Xia S, Kudinha T, Xiao S-N et al. Prevalence of ST1193 clone and IncI1/ST16 plasmid in E-coli isolates carrying blaCTX-M-55 gene from urinary tract infections patients in China. Sci Rep 2017; 7:44866 [View Article] [PubMed]
     [Google Scholar]
  26. Wu J, Lan F, Lu Y, He Q, Li B. Molecular characteristics of ST1193 clone among phylogenetic group B2 non-ST131 fluoroquinolone-resistant Escherichia coli. Front Microbiol 2017; 8:2294 [View Article] [PubMed]
     [Google Scholar]
  27. Johnson JR, Johnston BD, Porter SB, Clabots C, Bender TL et al. Rapid emergence, subsidence, and molecular detection of Escherichia coli sequence type 1193-fimH64, a new disseminated multidrug-resistant commensal and extraintestinal pathogen. J Clin Microbiol 2019; 57:e01664-18 [View Article] [PubMed]
     [Google Scholar]
  28. Rogers BA, Ingram PR, Runnegar N, Pitman MC, Freeman JT et al. Community-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countries. Antimicrob Agents Chemother 2014; 58:2126–2134 [View Article]
     [Google Scholar]
  29. Chang J, Yu J, Lee H, Ryu H, Park K et al. Prevalence and characteristics of lactose non-fermenting Escherichia coli in urinary isolates. J Infect Chemother 2014; 20:738–740 [View Article] [PubMed]
     [Google Scholar]
  30. Matsumura Y, Noguchi T, Tanaka M, Kanahashi T, Yamamoto M et al. Population structure of Japanese extraintestinal pathogenic Escherichia coli and its relationship with antimicrobial resistance. J Antimicrob Chemother 2017; 72:1040–1049 [View Article] [PubMed]
     [Google Scholar]
  31. Rogers BA, Ingram PR, Runnegar N, Pitman MC, Freeman JT et al. Sequence type 131 fimH30 and fimH41 subclones amongst Escherichia coli isolates in Australia and New Zealand. Int J Antimicrob Agents 2015; 45:351–358 [View Article] [PubMed]
     [Google Scholar]
  32. Kidsley AK, White RT, Beatson SA, Saputra S, Schembri MA et al. Companion animals are spillover hosts of the multidrug-resistant human extraintestinal Escherichia coli pandemic clones ST131 and ST1193. Front Microbiol 2020; 11:1968 [View Article] [PubMed]
     [Google Scholar]
  33. Platell JL, Trott DJ, Johnson JR, Heisig P, Heisig A et al. Prominence of an O75 clonal group (clonal complex 14) among non-ST131 fluoroquinolone-resistant Escherichia coli causing extraintestinal infections in humans and dogs in Australia. Antimicrob Agents Chemother 2012; 56:3898–3904 [View Article]
     [Google Scholar]
  34. Gomi R, Matsuda T, Fujimori Y, Harada H, Matsui Y et al. Characterization of pathogenic Escherichia coli in river water by simultaneous detection and sequencing of 14 virulence genes. Environ Sci Technol 2015; 49:6800–6807 [View Article]
     [Google Scholar]
  35. Cabal A, Peischl N, Rab G, Stöger A, Springer B et al. Draft genome sequence of a multidrug-resistant Escherichia coli sequence type 1193 pandemic clone isolated from wastewater in Austria. Microbiol Resour Announc 2021; 10:e0076221 [View Article] [PubMed]
     [Google Scholar]
  36. Tchesnokova V, Radey M, Chattopadhyay S, Larson L, Weaver JL et al. Pandemic fluoroquinolone resistant Escherichia coli clone ST1193 emerged via simultaneous homologous recombinations in 11 gene loci. Proc Natl Acad Sci USA 2019; 116:14740–14748 [View Article]
     [Google Scholar]
  37. Elazhary MA, Saheb SA, Roy RS, Lagacé A. A simple procedure for the preliminary identification of aerobic gram negative intestinal bacteria with special reference to the Enterobacteriaceae. Can J Comp Med 1973; 37:43–46 [PubMed]
     [Google Scholar]
  38. Mohsin M, Tanaka K, Kawahara R, Kondo S, Noguchi H et al. Whole-genome sequencing and comparative analysis of the genomes of Bacteroides thetaiotaomicron and Escherichia coli isolated from a healthy resident in Vietnam. J Glob Antimicrob Resist 2020; 21:65–67 [View Article] [PubMed]
     [Google Scholar]
  39. Biggel M, Hoehn S, Schmitt K, Frei A, Jans C et al. Complete genome sequence of Escherichia coli sequence type 1193 isolate AVS0096, recovered from river water in Switzerland. Microbiol Resour Announc 2021; 10:e0060721 [View Article] [PubMed]
     [Google Scholar]
  40. Goh KGK, Phan M-D, Forde BM, Chong TM, Yin W-F et al. Genome-wide discovery of genes required for capsule production by uropathogenic Escherichia coli. mBio 2017; 8:e01558-17 [View Article] [PubMed]
     [Google Scholar]
  41. Nhu NTK, Phan M-D, Peters KM, Lo AW, Forde BM et al. Discovery of new genes involved in curli production by a uropathogenic Escherichia coli strain from the highly virulent O45:K1:H7 lineage. mBio 2018; 9:e01462-18 [View Article] [PubMed]
     [Google Scholar]
  42. Nhu NTK, Phan M-D, Forde BM, Murthy AMV, Peters KM et al. Complex multilevel control of hemolysin production by uropathogenic Escherichia coli. mBio 2019; 10:e02248-19 [View Article] [PubMed]
     [Google Scholar]
  43. Hancock SJ, Lo AW, Ve T, Day CJ, Tan L et al. Ucl fimbriae regulation and glycan receptor specificity contribute to gut colonisation by extra-intestinal pathogenic Escherichia coli. . PLoS Pathog 2022; 18:e1010582 [View Article] [PubMed]
     [Google Scholar]
  44. Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics 2014; 30:2068–2069 [View Article] [PubMed]
     [Google Scholar]
  45. Zhou Y, Liang Y, Lynch KH, Dennis JJ, Wishart DS. PHAST: a fast phage search tool. Nucleic Acids Res 2011; 39:W347–W352 [View Article] [PubMed]
     [Google Scholar]
  46. Arndt D, Grant JR, Marcu A, Sajed T, Pon A et al. PHASTER: a better, faster version of the PHAST phage search tool. Nucleic Acids Res 2016; 44:W16–W21 [View Article]
     [Google Scholar]
  47. Bertelli C, Laird MR, Williams KP. Simon Fraser University Research Computing Group Lau BY et al. IslandViewer 4: expanded prediction of genomic islands for larger-scale datasets. Nucleic Acids Res 2017; 45:W30–W35 [View Article] [PubMed]
     [Google Scholar]
  48. Varani AM, Siguier P, Gourbeyre E, Charneau V, Chandler M. ISsaga is an ensemble of web-based methods for high throughput identification and semi-automatic annotation of insertion sequences in prokaryotic genomes. Genome Biol 2011; 12:R30 [View Article] [PubMed]
     [Google Scholar]
  49. Siguier P, Perochon J, Lestrade L, Mahillon J, Chandler M. ISfinder: the reference centre for bacterial insertion sequences. Nucleic Acids Res 2006; 34:D32–D36 [View Article] [PubMed]
     [Google Scholar]
  50. Rutherford K, Parkhill J, Crook J, Horsnell T, Rice P et al. Artemis: sequence visualization and annotation. Bioinformatics 2000; 16:944–945 [View Article] [PubMed]
     [Google Scholar]
  51. Darling AE, Mau B, Perna NT. progressiveMauve: multiple genome alignment with gene gain, loss and rearrangement. PLoS One 2010; 5:e11147 [View Article] [PubMed]
     [Google Scholar]
  52. Darling AC, Mau B, Blattner FR, Perna NT. Mauve: multiple alignment of conserved genomic sequence with rearrangements. Genome Res 2004; 14:1394–1403 [View Article] [PubMed]
     [Google Scholar]
  53. Treangen TJ, Ondov BD, Koren S, Phillippy AM. The harvest suite for rapid core-genome alignment and visualization of thousands of intraspecific microbial genomes. Genome Biol 2014; 15:524 [View Article]
     [Google Scholar]
  54. Croucher NJ, Page AJ, Connor TR, Delaney AJ, Keane JA et al. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids Res 2015; 43:e15 [View Article] [PubMed]
     [Google Scholar]
  55. Wickham H. Ggplot2: Elegant Graphics for Data Analysis New York, United States of America: Springer; 2016
     [Google Scholar]
  56. R Core Team A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2019 https://www.r-project.org/ accessed 3 November 2021
  57. Huang W, Li L, Myers JR, Marth GT. ART: a next-generation sequencing read simulator. Bioinformatics 2012; 28:593–594 [View Article]
     [Google Scholar]
  58. Sarovich DS, Price EP. SPANDx: a genomics pipeline for comparative analysis of large haploid whole genome re-sequencing datasets. BMC Res Notes 2014; 7:618 [View Article] [PubMed]
     [Google Scholar]
  59. Darriba D, Taboada GL, Doallo R, Posada D. jModelTest 2: more models, new heuristics and parallel computing. Nat Methods 2012; 9:772 [View Article] [PubMed]
     [Google Scholar]
  60. Guindon S, Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 2003; 52:696–704 [View Article] [PubMed]
     [Google Scholar]
  61. Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 2014; 30:1312–1313 [View Article] [PubMed]
     [Google Scholar]
  62. Pitout JDD, DeVinney R. Escherichia coli ST131: a multidrug-resistant clone primed for global domination. F1000Res 2017; 6: [View Article] [PubMed]
     [Google Scholar]
  63. Whitfield C. Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu Rev Biochem 2006; 75:39–68 [View Article] [PubMed]
     [Google Scholar]
  64. Whitfield C, Roberts IS. Structure, assembly and regulation of expression of capsules in Escherichia coli. Mol Microbiol 1999; 31:1307–1319 [View Article] [PubMed]
     [Google Scholar]
  65. Vann WF, Schmidt MA, Jann B, Jann K. The structure of the capsular polysaccharide (K5 antigen) of urinary-tract-infective Escherichia coli 010:K5:H4. A polymer similar to desulfo-heparin. Eur J Biochem 1981; 116:359–364 [View Article] [PubMed]
     [Google Scholar]
  66. Dewitt CW, Rowe JA. Sialic acids (N,7-O-diacetylneuraminic acid and N-acetylneuraminic acid) in Escherichia coli. I. Isolation and identification. J Bacteriol 1961; 82:838–848 [View Article] [PubMed]
     [Google Scholar]
  67. McGuire EJ, Binkley SB. The structure and chemistry of colominic acid. Biochemistry 1964; 3:247–251 [View Article] [PubMed]
     [Google Scholar]
  68. Kasper DL, Winkelhake JL, Zollinger WD, Brandt BL, Artenstein MS. Immunochemical similarity between polysaccharide antigens of Escherichia Coli 07:K1(L):NM and group B Neisseria Meningitidis. J Immunol 1973; 110:262–268 [View Article]
     [Google Scholar]
  69. Glynn AA, Howard CJ. The sensitivity to complement of strains of Escherichia coli related to their K antigens. Immunology 1970; 18:331–346 [PubMed]
     [Google Scholar]
  70. Cross AS, Zollinger W, Mandrell R, Gemski P, Sadoff J. Evaluation of immunotherapeutic approaches for the potential treatment of infections caused by K1-positive Escherichia coli. J Infect Dis 1983; 147:68–76 [View Article] [PubMed]
     [Google Scholar]
  71. Kim KS, Itabashi H, Gemski P, Sadoff J, Warren RL et al. The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat. J Clin Invest 1992; 90:897–905 [View Article] [PubMed]
     [Google Scholar]
  72. Alqasim A, Scheutz F, Zong Z, McNally A. Comparative genome analysis identifies few traits unique to the Escherichia coli ST131 H30Rx clade and extensive mosaicism at the capsule locus. BMC Genom 2014; 15:830 [View Article] [PubMed]
     [Google Scholar]
  73. Holt KE, Lassalle F, Wyres KL, Wick R, Mostowy RJ. Diversity and evolution of surface polysaccharide synthesis loci in Enterobacteriales. ISME J 2020; 14:1713–1730 [View Article] [PubMed]
     [Google Scholar]
  74. Croucher NJ, Finkelstein JA, Pelton SI, Mitchell PK, Lee GM et al. Population genomics of post-vaccine changes in pneumococcal epidemiology. Nat Genet 2013; 45:656–663 [View Article] [PubMed]
     [Google Scholar]
  75. Pi H, Jones SA, Mercer LE, Meador JP, Caughron JE et al. Role of catecholate siderophores in gram-negative bacterial colonization of the mouse gut. PLoS One 2012; 7:e50020 [View Article] [PubMed]
     [Google Scholar]
  76. Hagan EC, Lloyd AL, Rasko DA, Faerber GJ, Mobley HLT. Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog 2010; 6:e1001187 [View Article] [PubMed]
     [Google Scholar]
  77. Watts RE, Totsika M, Challinor VL, Mabbett AN, Ulett GC et al. Contribution of siderophore systems to growth and urinary tract colonization of asymptomatic bacteriuria Escherichia coli. Infect Immun 2012; 80:333–344 [View Article] [PubMed]
     [Google Scholar]
  78. Hubbard ATM, Mason J, Roberts P, Parry CM, Corless C et al. Piperacillin/tazobactam resistance in a clinical isolate of Escherichia coli due to IS26-mediated amplification of blaTEM-1B. Nat Commun 2020; 11:4915 [View Article] [PubMed]
     [Google Scholar]
  79. Forde BM, Henderson A, Playford EG, Looke D, Henderson BC et al. Fatal respiratory diphtheria caused by β-lactam-resistant Corynebacterium diphtheriae. Clin Infect Dis 2021; 73:e4531–e4538 [View Article] [PubMed]
     [Google Scholar]
  80. Sullivan MJ, Petty NK, Beatson SA. Easyfig: a genome comparison visualizer. Bioinformatics 2011; 27:1009–1010 [View Article] [PubMed]
     [Google Scholar]
/content/journal/acmi/10.1099/acmi.0.000894.v3
Loading
The complete genome sequence of five pre-2013 Escherichia coli sequence type (ST)1193 strains reveals insights into an emerging pathogen
Access Microbiology 6, 000894.v3 (2024); https://doi.org/10.1099/acmi.0.000894.v3
/content/journal/acmi/10.1099/acmi.0.000894.v3
/content/journal/acmi/10.1099/acmi.0.000894.v3
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Supplementary material 2

EXCEL

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error